871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

Released Wednesday, 19th March 2025
Good episode? Give it some love!
871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

871 - A Potentially “Game-Changing” Approach to Preventing Ovarian Cancer

Wednesday, 19th March 2025
Good episode? Give it some love!
Rate Episode

Episode Transcript

Transcripts are displayed as originally observed. Some content, including advertisements may have changed.

Use Ctrl + F to search

0:00

Welcome to Public Health

0:02

on Call, a podcast from

0:04

the Johns Hopkins Bloomberg School

0:06

of Public Health, where

0:09

we bring evidence, experience,

0:11

and perspective to make sense

0:13

of today's leading health challenges.

0:15

If you have questions or

0:18

ideas for us, please send

0:20

an email to Public Health

0:22

Question at JHU.EDU. That's Public

0:25

Health Question at JHU. EDU.

0:27

for future podcast episodes. Hi

0:29

listeners, it's Lindsay Smith-Rogers. Today,

0:32

a look at preventing ovarian

0:34

cancer, which can be difficult

0:36

to diagnose and treat. Stephanie

0:38

Desmond talks to Dr. Rebecca

0:40

Stone, the director of gynecologic

0:42

oncology at Johns Hopkins, about

0:44

changes in how we understand

0:46

ovarian cancer, that much of

0:49

what is called ovarian cancer

0:51

may actually start in the

0:53

fallopian tubes. and about an

0:55

under-use surgery that preserves ovaries

0:57

and may save lives. Let's

0:59

listen. Rebecca Stone, thanks so

1:01

much for joining me. Thank you so

1:03

much for having me. It's a real

1:05

pleasure. So today I want to

1:07

talk about something with a difficult

1:10

name to say, but it actually

1:12

could save a lot of people's

1:14

lives. So we're talking about salpingectomy,

1:16

which is the removal of the

1:19

fallopian tubes, and I understand that

1:21

this could really... a game changer

1:23

in ovarian cancer. Could you talk

1:25

to me a little bit about,

1:27

maybe about, let's start with ovarian

1:29

cancer, right? It's hard to screen

1:31

war and it's deadly, and this

1:33

can reduce the risk. Tell me,

1:35

please. I think sometimes when I talk

1:38

to people about this, the first thing,

1:40

they're thinking is, well, okay,

1:42

you're talking to me about ovarian

1:44

cancer, and then you're talking about

1:46

a structure that's not the

1:48

ovary. You're talking about the

1:50

fallopian tube, and so How do you

1:53

make sense of those two things? And

1:55

this is the fact that we're

1:57

talking about the fallopian tube is

1:59

real. to a

2:01

relatively recent scientific discovery that

2:03

a large number of ovarian

2:05

cancers or types of cancer

2:07

that we have historically called

2:09

ovarian cancer actually originate either

2:11

directly or indirectly from the

2:13

fallopian tube and you know

2:15

many people have not thought

2:17

about gynecologic anatomy or function

2:20

ever or maybe it was

2:22

many many years ago but

2:24

you may remember the fallopian

2:26

tube is this small thin

2:28

structure that arises from the

2:30

top of the uterus or

2:32

the womb and sits immediately

2:34

adjacent to the ovary and

2:36

so when the ovary produces

2:38

an egg the fallopian tube

2:40

grabs that egg and the

2:42

egg goes into the tube

2:44

and then maybe if it

2:46

meets a sperm there, there's

2:48

fertilization event and then pregnancy

2:50

can happen. And so you

2:52

can imagine that if when

2:54

a cancer starts in either

2:56

the fallopian tube or ovary,

2:58

it sometimes might be hard

3:00

to discern, you know, which

3:02

was truly the primary site

3:04

of the cancer because they're

3:06

so, you know, they're, we

3:09

always say they're frenemies or

3:11

they live so, you know,

3:13

they live so, you know,

3:15

closely next to each other.

3:17

And so, you know, in

3:19

medicine historically, there has been

3:21

a group of cancers that

3:23

we have called ovarian cancer.

3:25

And I tell people, maybe

3:27

it helps to think about

3:29

the ovary sort of like

3:31

a grape. And you might

3:33

think a grape sort of

3:35

has three layers. It has

3:37

the skin of the grape,

3:39

the fruit of the grape,

3:41

and then the seed, like

3:43

the germanal center. and traditionally

3:45

ovarian cancers have been attributed

3:47

to one of those three

3:49

layers. With the most, the

3:51

highest prevalence or most common

3:53

types of rising... from what

3:55

people thought to be from

3:57

the skin of the grape.

4:00

And that maybe is like

4:02

90% of ovarian cancers historically

4:04

were attributed to the skin

4:06

of the grape and only

4:08

about 10% to the fruit

4:10

or the sea, the Germanal

4:12

center. But as you know,

4:14

people have really studied ovarian

4:16

cancer and looked at, you

4:18

know, what do the cells

4:20

look like under the microscope?

4:22

and we've started to learn

4:24

more about, particularly about people

4:26

and families that have this

4:28

hereditary risk of ovarian cancer,

4:30

we really have come to

4:32

accept that many of the

4:34

cancers that we thought arose

4:36

from the skin of the

4:38

grape, the surface of the

4:40

ovary, actually appear to come

4:42

from the end of the

4:44

fallopian tube that sits right

4:46

next to the ovary. And

4:48

so if you Google ovarian

4:51

cancer... you will often see

4:53

pictures of and read about

4:55

a type called high-grade cirrus

4:57

cancer, which is the most

4:59

common and deadly type of

5:01

cancer that people had traditionally

5:03

attributed to the ovary. In

5:05

most cases, it comes from

5:07

that end of the fallopian

5:09

tube. So, that then brings

5:11

us to, you know, why

5:13

are people talking about the

5:15

fallopian tube so much because...

5:17

Now that we really understand

5:19

that most types of ovarian

5:21

cancer, most cases of ovarian

5:23

cancer are starting in the

5:25

tube instead of the ovary,

5:27

explains why in medicine we've

5:29

never been able to develop

5:31

a screening test because, you

5:33

know, many of our screening

5:35

tests have relied on imaging,

5:37

like ultrasound, but there really

5:40

is no imaging in medicine

5:42

that can routinely see a

5:44

fallopian tube. Which is shocking

5:46

to most people. I mean,

5:48

it was sort of shocking

5:50

to me, and I'm a

5:52

doctor, right? And I've, you

5:54

know, this has been an

5:56

area of interest of mine

5:58

for many, many years. And

6:00

when you really sit down

6:02

and think about it, the

6:04

fact that we actually don't

6:07

have imaging for a critical

6:09

structure in the body, like the

6:11

fallopian tube, is surprising.

6:13

So what do we do about that?

6:15

I think this is the question of

6:18

the day, right, which is if we

6:20

can't screen for ovarian cancer, right,

6:22

with imaging or blood tests,

6:25

and it's a cancer that

6:27

we don't have... a reliable

6:29

way to eradicate, meaning we

6:31

can't cure it in many cases,

6:33

it's very dangerous, then is

6:36

there something that we could do

6:38

to prevent it? You know, when you

6:40

think about the option for prevention

6:42

being ovarian removal, well that's

6:45

not so great because the

6:47

ovaries are an important endocrine

6:49

organ, probably well past menopause,

6:52

and this is a real

6:54

active area of research. So,

6:56

you know, the idea that we

6:58

could prevent a cancer by removing

7:01

the ovaries is not so exciting,

7:03

but knowing that to prevent

7:05

ovarian cancer or many

7:07

cases of ovarian cancer

7:09

in a way that doesn't involve

7:11

removing the ovaries, but

7:13

rather the fallopian tube, which

7:16

in medicine doesn't have any

7:18

known form or function once

7:20

a person has completed

7:22

family planning. Well, that's actually

7:25

a more interesting idea

7:27

because the fallopian tube

7:29

doesn't make any hormones like the

7:31

ovary and its job in life

7:34

is to help with pregnancy. And

7:36

so if either someone doesn't want

7:39

pregnancy or they're never

7:41

planning on pregnancy, then

7:43

removal of the fallopian tube can

7:45

be a very good option

7:47

for prevention of... this

7:49

type of cancer that has a

7:51

misnomer now, right? We've called it

7:54

ovarian cancer, when in fact it

7:56

is largely fallopian tube cancer. And,

7:58

you know, the next most... common people

8:00

ask, question people ask is like,

8:02

well, how successful is this? Right?

8:04

How good is this as a

8:07

preventive strategy? And so I tell

8:09

people, well, when you think about

8:11

the most common and deadly type

8:13

of ovarian cancer, this type called

8:15

high grade cirrus, fallopian tube removal

8:17

right now, based upon existing data,

8:20

it's projected to prevent about 80

8:22

% of those cases, which is

8:24

just like amazing. And when you

8:26

think about ovarian cancer in general,

8:28

memory told you, not all not

8:31

all cancers come from the fallopian

8:33

tube. Some still primarily come from

8:35

the ovary. If you were to

8:37

look at what fraction of ovarian

8:39

cancer in general does fallopian tube

8:41

removal prevent, it's probably on the

8:44

order of maybe 50 to 65%.

8:46

So still the majority, which is,

8:48

which is very impressive. And it's

8:50

a procedure that is generally speaking,

8:52

you know, can be done as

8:55

standalone outpatient surgery. It could be

8:57

done in lieu of like a

8:59

tubal ligation, right, which is probably

9:01

the most common time in a

9:03

person's life when they might be

9:05

considering a self -inject me, fallopian tube

9:08

removal. You're thinking about getting your

9:10

tubes tied or it can be

9:12

a procedure that is done at

9:14

the same time as another procedure.

9:16

And that's often called opportunistic, meaning

9:19

taking the opportunity to offer somebody

9:21

preventative surgery. Or ovarian cancer. So

9:23

it could be done at hysterectomy

9:25

or people are starting to think

9:27

about what are the other scenarios

9:29

when it could be done. And

9:32

lots of people have surgery on

9:34

their abdomen in their, we say

9:36

post reproductive years. So they have

9:38

hernia, a pair, is it maybe

9:40

their gallbladder out or more other

9:43

procedures when, if they knew this

9:45

was an option, they might know

9:47

they could ask their surgeon about,

9:49

about the chance. So this is

9:51

not commonly known though. Tell me

9:53

about why we don't know much

9:56

about this. And also you make

9:58

it sound super easy. And I

10:00

imagine. it's not as easy as you've just made it

10:02

sound. It's not so hard but you

10:04

know I think there are lots of

10:07

considerations and we could talk briefly about

10:09

those. I think the first question is

10:11

why don't people know about this and

10:13

and a lot of people you know

10:15

they're kind of what's the word you know

10:18

shocked and surprised that they don't know

10:20

about this because it seems like such

10:22

an important discovery and it is you

10:25

know in health. Really, this has

10:27

been something that has been

10:29

embraced in the field of

10:31

OBGYN, particularly when thinking about

10:33

taking the opportunity to reduce

10:35

risk at the time of

10:37

like a hysterectomy. But

10:39

beyond that, people have not

10:42

really committed to creating, you

10:44

know, knowledge mobilization around this for

10:46

whatever reason. I mean, primarily, you

10:48

know, we're not good at this

10:51

in medicine, right? We're not good

10:53

at... conveying complex things

10:55

or telling people about

10:57

new scientific discovery. It's

11:00

just something that medicine

11:02

has not done well,

11:04

unfortunately. And there are some

11:07

barriers to implementing this in

11:09

the field of OBGYN and

11:11

then into surgical practice more

11:13

broadly. You know, in the

11:15

field of OBGYN, I had mentioned

11:17

one of the most common

11:20

times that a person might

11:22

consider a salpingectomy would be

11:24

at the time of permanent

11:26

contraception, right? So tubalagation. There

11:28

are some structural barriers to

11:30

being able to have access to

11:32

or to choose a salpingectomy instead

11:34

of a tubalagation. One of them,

11:37

you know, being like, for instance,

11:39

in our state and in a

11:41

number of other states, there's outdated

11:43

health policy. And there's also

11:45

not a insurance infrastructure

11:48

that is fail safe

11:50

to guarantee coverage. And that's

11:52

something that you know we are

11:54

really working on a lot of

11:57

advocacy to address. And then in

11:59

terms of translating this into surgical

12:01

practice more broadly, that has a

12:03

lot of important considerations. You know,

12:06

one being that it shouldn't be

12:08

something that a woman, we think,

12:10

or a person hears about for

12:13

the first time, you know, when

12:15

they are needing to have their

12:17

gallbladder out, right? This is really

12:19

something that someone should hear about,

12:22

you know, during their engagement in

12:24

their health throughout their lifetime. really

12:26

hasn't happened. Right now I think

12:29

people are thinking, okay, well, you

12:31

know, if a person needs X,

12:33

Y, Z procedure, you know, they

12:36

could, like they're coming into the

12:38

doctor for it or, you know,

12:40

God forbid they're in their emergency

12:42

or whatever, you know, they could

12:45

receive counseling about this at that

12:47

time, but it's not the most

12:49

ideal time for something like that

12:52

to happen. And it's better if

12:54

people have heard about this throughout

12:56

their health journey and they're prepared.

12:59

consider having a tubalagation for instance

13:01

and I think I might prefer

13:03

a cell conjectony instead or if

13:06

I need a hysterectomy I know

13:08

to talk to my doctor about

13:10

this or I know that if

13:12

I end up in my post-reproductive

13:15

years needing surgery for something that

13:17

I would like to also have

13:19

this. So it's sort of something

13:22

that the patient plans and they're

13:24

empowered to plan and choose. And

13:26

the other reason is that there

13:29

haven't been a lot of education

13:31

materials created about this in OBGYN,

13:33

let alone materials that could be

13:35

used by doctors that are non-obGYN

13:38

doctors who are not familiar with

13:40

counseling people about reproductive anatomy and

13:42

physiology and alternatives even, right? I

13:45

think that the alternatives part of

13:47

it is also really important because

13:49

there are options besides surgery to

13:52

decrease the risk of ovarian cancer.

13:54

For instance, we've known for a

13:56

long time that when people take

13:58

birth control pills, particularly for a

14:01

prolonged period of time or for

14:03

at least five years in their

14:05

life, that that decreases the risk

14:08

of ovarian cancer as well, probably

14:10

upwards of 40 to 50%. So

14:12

if somebody were to have, for

14:15

example, an ovarian cancer gene, this

14:17

could really be a solution that

14:19

is less damaging than, say removing

14:22

the ovaries. Yeah, so I think

14:24

what you're asking is if you

14:26

have had genetic testing due to

14:28

typically a family history, right, where

14:31

there are a number of people

14:33

who have been affected by breast

14:35

cancer, ovarian cancer, sometimes pancreatic cancer,

14:38

or colon cancer, what about the

14:40

option of removing the fallopian tube

14:42

instead of the ovary, for instance?

14:45

And I think that's a really

14:47

good question. That's something that that

14:49

is being studied right now. And

14:51

as you pointed out, the standard

14:54

of care for people who have

14:56

a high risk of developing ovarian

14:58

cancer in their lifetime due to

15:01

a gene mutation, for instance, and

15:03

these people, you know, have upwards

15:05

of a 40% chance of developing

15:08

ovarian cancer by age 80, the

15:10

standard of care has been removal

15:12

of the ovaries. And really, the

15:14

fallopian tube was just along for

15:17

the ride, right, when this started

15:19

in the early 2000s. you know

15:21

people would remove the ovary, the

15:24

fallopian tube would be removed as

15:26

well because there's no point in

15:28

keeping the fallopian tube if you're

15:31

taking the ovaries out and they

15:33

share a blood supply and people

15:35

would look at the ovary and

15:37

they couldn't never find any evidence

15:40

that ovarian cancer started there until

15:42

people started looking at the fallopian

15:44

tube and so really from this

15:47

emerged the idea of you know

15:49

maybe we were going about it

15:51

all wrong and We actually need

15:54

to focus on fallopian tube removal

15:56

instead of ovarian removal. But we

15:58

don't know for sure yet. And

16:01

we know that risk reducing surgery

16:03

as it has been done since

16:05

early 2000. which means removal of

16:07

the tube and the ovary on

16:10

both sides, is highly effective at

16:12

preventing ovarian cancer. You know, anywhere

16:14

between near 100% to somewhat less

16:17

than that, depending upon what's found

16:19

in the fallopian tube at the

16:21

time of risk-producing surgery. But we

16:24

don't know how effective it is

16:26

to just have the fallopian tube

16:28

out and to keep the ovary.

16:30

or to do what's called a

16:33

stage surgery where you have the

16:35

fallopian tubes out as soon as

16:37

you've completed family planning and you

16:40

wait to have the ovaries out

16:42

until you're closer to the natural

16:44

age of metapoles. What is your

16:47

aim here? So my aim, I'm

16:49

a person who takes care of

16:51

a lot of patients and families

16:53

who are affected by this disease

16:56

and who suffer from this disease

16:58

and die from it. And it

17:00

has really been one of the

17:03

most important areas of clinical medicine

17:05

for me throughout my life. And

17:07

I've dedicated countless hours and love

17:10

and devotion to it. And sitting

17:12

honestly with my patients, many patients

17:14

who are suffering from this, their

17:17

life, I have promised them that

17:19

I would continue to work on.

17:21

developing opportunities to prevent the disease,

17:23

truly like in their honor. And

17:26

that is literally what motivates me.

17:28

And you know, it's gotten to

17:30

the point, Stephanie, where I honestly

17:33

couldn't sleep anymore, knowing that, you

17:35

know, so many people in the

17:37

United States have an opportunity to

17:40

know about this and to choose

17:42

it, right? Because people actually choose

17:44

to litigation more than any. other

17:46

method of family planning in the

17:49

United States. Lots of people have

17:51

hysterectomies and other surgeries where, you

17:53

know, if they knew about this,

17:56

they could have the opportunity to...

17:58

bent the disease,

18:01

that people didn't know about this,

18:03

that this was so siloed in the

18:05

field of OBGYN, I

18:07

couldn't sleep anymore about it. And so I just

18:09

decided I was just gonna work on it and

18:11

for the rest of my life until I got

18:14

as far as I could. So you're

18:16

out here spreading the word. Rebecca Stone, thank

18:18

you so much for your time. Of

18:20

course, thank you so much for having

18:23

me and for really caring about

18:25

this. MUSIC Public

18:29

Health On Call is a

18:31

podcast from the Johns

18:33

Hopkins Bloomberg School of Public

18:35

Health, produced by Joshua

18:37

Sharfstein, Lindsay Smith Rogers, Stephanie

18:39

Desmond, and Grace Fernandez -Sissiri.

18:41

Audio production by J .B.

18:44

Arbogast, Michael Bonfills, Spencer

18:46

Greer, Matthew Martin, and Phillip

18:48

Porter, with support from

18:50

Chip Hickey. Distribution by Nick

18:52

Moran. Production Coordination by

18:54

Catherine Ricardo. Social Media, run

18:56

by Grace Fernandez -Sissiri. Analytics

18:59

by Alisa Rosen.

19:01

If you have questions

19:03

or ideas for

19:05

us, please send an

19:07

email to publichealthquestionatjhu .edu.

19:09

That's publichealthquestionatjhu .edu for

19:11

future podcast episodes. Thank

19:14

you for listening. MUSIC

19:23

.

Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features